Related Experiment Videos
Rapid progressive hepatitis C after liver transplantation: a case report
1Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. tochiogou@yahoo.co.jp
Insights
Hepatitis C rapidly recurred after a liver transplant in a patient on hemodialysis. Immunosuppression from hemodialysis and splenectomy likely contributed to the aggressive Hepatitis C virus (HCV) recurrence post-transplant.
Area of Science:
- Hepatology
- Transplantation Immunology
- Virology
Background:
- Hepatocellular carcinoma (HCC) in patients with liver cirrhosis often necessitates liver transplantation.
- Living-related donor liver transplantation (LRDLT) is a viable option for end-stage liver disease.
- Hepatitis C virus (HCV) recurrence post-transplantation is a significant clinical challenge.
Observation:
- A 56-year-old male with chronic renal failure on hemodialysis underwent LRDLT and splenectomy for liver cirrhosis (HCV genotype 1b) with HCC.
- Postoperative day 69, the patient developed fever and elevated liver enzymes, indicating liver dysfunction.
- Liver biopsy confirmed rapid recurrence of progressive Hepatitis C infection.
Findings:
- Treatment with Interferon beta (IFNβ) normalized liver function.
- HCV-RNA levels decreased significantly post-treatment, indicating viral load reduction.
- The patient's immunosuppression, potentially exacerbated by hemodialysis and splenectomy, was inferred as the cause of rapid HCV recurrence.
Implications:
- Hemodialysis and splenectomy may increase the risk of aggressive HCV recurrence after LRDLT.
- Early diagnosis and prompt antiviral therapy are crucial for managing post-transplant HCV recurrence.
- Further research is needed to understand the interplay between immunosuppression, renal failure, and HCV recurrence in liver transplant recipients.
Abstract:
A 56-year-old man on hemodialysis for 3 years because of chronic renal failure underwent living related donor liver transplantation (LRDLT) and splenectomy using the right hepatic lobe for liver cirrhosis type C (genotype 1b) with hepatocellular carcinoma. At 69 postoperative days (POD), he displayed a high fever and his blood transaminase and total bilirubin were increased. Based on finding in his liver biopsy, we diagnosed rapid recurrence of progressive hepatitis C after LRDLT, so we administered IFNbeta. Thereafter his liver function returned to normal and his HCV-mRNA decreased to 1200 kcopy/mL. We inferred that hemodialysis and splenectomy decreased his immunity, allowing rapidly progressive hepatitis C recurrence after LRDLT.
Related Concept Videos
Hepatitis
Cirrhosis I: Introduction